How repurposing the former Novartis plant aligns with IPP’s commitment to the circular economy and community revitalization.

Key regulatory trends laying the foundation for updated policies, risk-based regulatory frameworks, and forward-looking ...

Otulfi, an ustekinumab biosimilar for the reference product Stelara (ustekinumab), developed by Formycon AG, is now available ...

To gain deeper insights into the role of pre-filled syringes in patient-centric packaging, we spoke with Dexter Tjoa, CEO of ...

Callio Therapeutics, a biotechnology company, has launched with the closing of a $187.0 million Series A financing round.

Ralston brings more than 25 years of experience providing strategic Market Access and HEOR solutions.

Glenmark Pharmaceuticals Inc. USA has acquired and launched Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose ...

The US Food and Drug Administration (FDA) has accepted for review GSK’s Biologics License Application for depemokimab.

AbbVie and Gubra have partnered to develop GUB014295, a potential best-in-class, long-acting amylin analog for the treatment of obesity.

Veranova has moved its corporate headquarters to its Devens, Massachusetts site, one of its principal sites for manufacturing and development.

Magnet Biomedicine, a biopharmaceutical company advancing molecular glue discovery, has entered a collaboration and license ...

Direct Data API, a new class of API, is now included for no additional license fee as part of Veeva Vault Platform.